Search results
Found 25959 matches for
A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance
Dr Yiqi Zhao wins the inaugural Peter Medawar Prize for Immunology
9 May 2024
The 2024 prize was awarded to Dr Yiqi Zhao (Dunn School) for her outstanding contribution to understanding innate immunity and viral evasion, and wider contributions to the immunology community.
New study maps the crucial factors in inflammation control
8 May 2024
A Cell Reports study from the Target Discovery Institute and CAMS Oxford Institute provides an intricate time-resolved molecular map of different phases of NLRP3 inflammasome activation and unveils ubiquitin C-terminal hydrolase 1 (UCH-L1) as a modulator of NLRP3 inflammasome assembly and IL-1β production.
NDM-CGHR Director announcement
7 May 2024
Professor Susanna Dunachie has been appointed to the new role of Director of the NDM Centre for Global Health Research
Ground-breaking study reveals how COVID-19 vaccines prevent severe disease
7 May 2024
A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
Nature Nanotechnology study introduces new and improved version of all-in-one coronavirus vaccine
7 May 2024
CAMS Oxford Institute researchers publish an improved version of a novel all-in-one vaccine against coronavirus threats in Nature Nanotechnology.
Researchers discover how immune cells hunt down cancer around the body
3 May 2024
Scientists have discovered the key features of immune B cells which make them successful at targeting tumours - including when cancer has spread to a different part of the body.
Dr Ashwin Jainarayanan selected for 2024 Schmidt Science Fellow program
1 May 2024
Dr Ashwin Jainarayanan has been selected to become a 2024 Schmidt Science Fellow – an honour bestowed on only 32 exceptional early career researchers worldwide. The 2024 Fellows, nominated by 26 of the world’s leading institutions across North America, Europe, and Asia, were chosen for their potential to drive sector-wide change by pursuing ambitious interdisciplinary science projects.
New study to improve vaccines and therapeutics development
NDM
1 May 2024
A first-of-its-kind study led by the University of Oxford has successfully investigated human immunity against COVID-19 in people who already have antibodies against it.
Unveiling of Medawar Nobel Prize medal
29 April 2024
On Thursday 25th April 2024, the Oxford immunology community celebrated the kind donation of Sir Peter Medawar’s Nobel Prize medal to the University.
Immunology at the MRC WIMM
WIMM
29 April 2024
For International Day of Immunology 2024, three scientists from the MRC Translational Immune Discovery Unit speak about their research.
The potential of the R21/Matrix vaccine to redefine malaria prevention
25 April 2024
Researchers from the Jenner Institute at NDM will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Rwandan Ministry of Health and the Rwanda Biomedical Centre.
British Heart Foundation Programme grant will explore the molecular immunology of heart and vessel disease
23 April 2024
A new programme of research led by Professor Claudia Monaco and funded by the British Heart Foundation aims to unpick the inflammatory processes behind cardiovascular disease so that immune-targeted therapies may be developed in future.
New trial using skin patches as an ‘early warning system’ to spot lung transplant rejection
17 April 2024
A new trial, SENTINEL, is set to investigate if skin patches can be used as an early warning system to identify if lung transplants are being rejected, so treatment can begin sooner, reducing the chance of longer lasting organ damage.
Serum Institute of India and University of Oxford strike landmark licensing agreement for Meningitis-B vaccine
16 April 2024
Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines.
Aerosol human infection model gives hope for TB vaccine development
16 April 2024
University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs – the way TB enters the body.
New study reveals how T cells gain and maintain tolerance to gut bacteria
3 April 2024
The immune system in the intestine maintains a careful balance, tolerating our long-term resident (commensal) gut bacteria while defending against invading pathogens. Under certain circumstances, dysregulation of our intestinal immune response to commensal and pathogenic microbes can drive inflammatory disease.
Novel pairing of proteins controls tumour growth
3 April 2024
New research by the CAMS Oxford Institute, the MRC Translational Immune Discovery Unit and the Kennedy Institute researchers describes a novel pairing of integrins which could improve T cell control of cancer.
Thanks for the Memories Immunology Workshop at the Science and Industry Museum, Manchester
28 March 2024
The Thanks for the Memories public engagement programme – bringing together the worlds of immunology research and music composition for secondary school students in Manchester and Oxford – had a fantastic day with Manchester Co-op Academy students at the Science and Industry Museum in Manchester on Friday 8th March.
Developing the world's first lung cancer vaccine
26 March 2024
Researchers at the Nuffield Department of Medicine, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine. The group includes Professor Tim Elliott, Kidani Professor of Immuno-oncology at NDM.
PD-1 gets an “A” for team-work
8 March 2024
A new understanding of the PD-1 axis (programmed death cell) could help shape ongoing efforts to improve treatments for cancer and autoimmune diseases.